Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-122021
Filing Date
2020-11-05
Accepted
2020-11-05 20:03:20
Documents
2
Period of Report
2020-10-26

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1507
2 EX-24.1 ex-24d1.htm EX-24.1 7838
  Complete submission text file 0001104659-20-122021.txt   10666
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341
Business Address
Stoneman Sandra G. (Reporting) CIK: 0001831144 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39580 | Film No.: 201292071